The DOI matches its Crossref record; 14 of the 16 references it cites were found in a registry or an index.
Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease
Abstract
The safety and tolerability of high dosages of coenzyme Q10 were studied in 17 patients with Parkinson's disease (PD) in an open label study. The subjects received an escalating dosage of coenzyme Q10--1200, 1800, 2400, and 3000 mg/day with a stable dosage of vitamin E (alpha-tocopherol) 1200 IU/day. The plasma level of coenzyme Q10 was measured at each dosage. Thirteen of the subjects achieved the maximal dosage, and adverse events were typically considered to be unrelated to coenzyme Q10. The plasma level reached a plateau at the 2400 mg/day dosage and did not increase further at the 3000 mg/day dosage. Our data suggest that in future studies of coenzyme Q10 in PD, a dosage of 2400 mg/day (with vitamin E/alpha-tocopherol 1200 IU/day) is an appropriate highest dosage to be studied.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, plasma CoQ10 levels reached a plateau at the 2400 mg/day dosage and did not increase further at the 3000 mg/day dosage in PD, HD or ALS patients161, 162.”
From Mitochondrial Approaches for Neuroprotection (2008) · cites this paper as [161]
Citations
Cites
Effects of Coenzyme Q10 in Early Parkinson Disease: Evidence of Slowing of the Functional Decline
Shults, C. W. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1541 · Cited by 984
Self-citationStocker, R., Bowry, V. W., & Frei, B. B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1646 · Cited by 797
Mohr, D., Bowry, V. W., & Stocker, R. (1992) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(92)90237-p · Cited by 313
Biomedical and clinical aspects of coenzyme Q
Littarru, G. P. (1993) · Journal of Molecular Medicine · doi:10.1007/bf00184478 · Cited by 310
Lass, A., & Sohal, R. S. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0606 · Cited by 162
Lass, A., & Sohal, R. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.1.87 · Cited by 128
Bioavailability of four oral Coenzyme Q10 formulations in healthy volunteers
Weis, M., Mortensen, S. A., Rassing, M. R., Sonnergaard, J. M., Poulsen, G., & Rasmussen, S. N. (1994) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(94)90038-8 · Cited by 102
Kontush, A., Hübner, C., Finckh, B., Kohlschütter, A., & Beisiegel†, U. (1995) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00115-s · Cited by 75
Pharmacokinetic study of deuterium-labelled coenzyme Q10 in man.
Tomono, Y., Hasegawa, J., Seki, T., Motegi, K., & Morishita, N. (1986) · PubMed · Cited by 73
Interactions between ubiquinones and vitamins in membranes and cells
Constantinescu, A., Maguire, J. J., & Packer, L. (1994) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(94)90013-2 · Cited by 73
Cited by
Sorted by citations
Targeting Antioxidants to Mitochondria by Conjugation to Lipophilic Cations
Murphy, M. P., & Smith, R. A. J. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105110 · Cited by 1,173
Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target
Barber, S. C., & Shaw, P. J. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.11.018 · Cited by 647
Coenzyme Q10: Absorption, tissue uptake, metabolism and pharmacokinetics
Bhagavan, H. N., & Chopra, R. K. (2006) · Free Radical Research · doi:10.1080/10715760600617843 · Cited by 550
Mitochondrial Diseases of the Brain
Chaturvedi, R. K., & Beal, M. F. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.03.018 · Cited by 426
A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease
The Parkinson Study Group QE3 Investigators, Beal, M. F., Oakes, D., Shoulson, I., Henchcliffe, C., Galpern, W. R., Haas, R., Juncos, J. L., Nutt, J. G., Voss, T., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.131 · Cited by 410
Self-citation
Metadata
- Authors
- Shults, C. W., Flint Beal, M., Song, D., & Fontaine, D.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Shults, Clifford W.
- ORCID
- Song, David
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2004-08
- Volume
- 188
- Issue
- 2
- Pages
- 491-494
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W1990908870
- Cited by
- 223
- References
- 16
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 1 · 2023: 8 · 2022: 8 · 2021: 10 · 2020: 8 · 2019: 6 · 2018: 6 · 2017: 7 · 2016: 9 · 2015: 7 · 2014: 13 · 2013: 13 · 2012: 13
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- coenzyme Q10, Parkinson's disease, high-dose supplementation, vitamin E, alpha-tocopherol, safety and tolerability, dose escalation, adverse events
- MeSH terms
- Calcium, Coenzymes, Cognition, Dose-Response Relationship, Drug, Drug Therapy, Combination, Dyspepsia, Female, Humans, Male, Middle Aged, Motor Activity, Parkinson Disease, Pilot Projects, Safety, Time Factors, Ubiquinone, Vitamin E
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
